SpaceX IPO Is Coming, 10 Things Retail Investors Need to Know

Technology

RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough

Life Science

Is AMD Too Expensive? Bank of America Stands Bullish

Technology

Breaking Down VKTX: 188% Upside, Pipeline Progress and Key Risks

Life Science

Why Cathie Wood Is Selling AMD and Buying Nvidia Now

Technology

Has Apple Finally Claimed Its Seat at the AI Rally?

Technology

GSK Pays 40% Premium to Buy Nuvalent in Major Oncology Push

Life Science

Apple Announces AI Progress at WWDC, Partners with Google and Nvidia to Build Cloud-Based Models

Technology

Global LNG Frenzy: 4 High-Potential Stocks to Ride the Boom

Energy

Marvell Tapped for S&P 500: Can the AI Chip Rival Emerge as the Next Nvidia?

Technology

AI Selloff: Should Investors Buy the Dip or Shift to Value Stocks?

Financial Service, Technology

Should You Buy SpaceX Stock at Its IPO? 3 Pros and 2 Cons

Technology

After a 6% Drop, Nvidia Faces a Bigger Threat: Its Own Customers

Technology

These Two Canadian Dividend Stocks Balance Low Volatility with Long-Term Growth Potential

Energy

RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy?

Life Science